Humans ; Infant ; Infant Food ; Infant, Newborn ; Triazines ; toxicity ; Urinary Calculi ; chemically induced

Child ; Evidence-Based Medicine ; Glomerulonephritis, IGA ; diagnosis ; therapy ; Guidelines as Topic ; Humans

Child ; Child, Preschool ; China ; epidemiology ; Evidence-Based Medicine ; Humans ; Kidney Diseases ; diagnosis ; epidemiology ; therapy ; Practice Guidelines as Topic

Child ; Diagnosis, Differential ; Humans ; Kidney Diseases ; diagnosis ; genetics ; therapy ; Nephrotic Syndrome ; diagnosis ; therapy ; Prenatal Diagnosis

Child ; Evidence-Based Medicine ; Humans ; Kidney Diseases ; diagnosis ; therapy ; Practice Guidelines as Topic

Child ; Congresses as Topic ; Humans ; Nephrology ; Pediatrics

Biomedical Research ; education ; methods ; trends ; Humans ; Kidney Diseases ; complications ; genetics ; Kidney Failure, Chronic ; genetics ; Meta-Analysis as Topic

Aristolochic Acids ; adverse effects ; Drugs, Chinese Herbal ; adverse effects ; Female ; Follow-Up Studies ; Glomerular Filtration Rate ; Humans ; Infant, Newborn ; Kidney Diseases ; chemically induced ; Kidney Tubular Necrosis, Acute ; chemically induced ; Magnoliopsida ; adverse effects ; Male ; Retrospective Studies

Humans ; Multicenter Studies as Topic

33 patients with chronic atrophic gastritis were divided into 2 groups. Among them, 19 patients were treated with small doses of pentagastrin for 8 weeks, whereas the other 14 served as a control group. The therapeutic effect was decided by overall observations of the subjective symptoms, biopsy of the gastric mucosa and the change in cytodynamics before and after the treatment. The results showed that small doses of pentagastrin can markedly relieve the clinical symptoms of atrophic gastritis, lessen the pathological changes to some extent, and reduce labelling indices in a part of the patients with a-trophic gastritis in the gastric body. The treatment showed no definite therapeutic effect on atrophic gastritis in the gastric antrum.